11/25/2025
Eli Lilly’s Blood Cancer Drug Jaypirca Shows Promise in Trial as Early Treatment! Eli Lilly reported that its blood cancer therapy drug, Jaypirca, showed promise as a potential first-line treatment option by delaying disease progression in previously untreated patients. Lilly’s new drug, Jaypirca (pirtobrutinib), treats blood cancers like chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Lilly said it plans to conduct further analysis next year of overall survival rates, another meaningful way of measuring a drug’s effectiveness... https://bit.ly/4igKfBr
Eli Lilly reported that its blood cancer therapy drug, Jaypirca, showed promise as a potential first-line treatment option by delaying disease progression in previously untreated patients.Lilly’s new drug, Jaypirca (pirtobrutinib), treats blood cancers like chronic lymphocytic leukemia (CLL) and s...